Mark MacMahon

519 total citations
16 papers, 402 citations indexed

About

Mark MacMahon is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark MacMahon has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark MacMahon's work include Lipoproteins and Cardiovascular Health (6 papers), Pharmacology and Obesity Treatment (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Mark MacMahon is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Pharmacology and Obesity Treatment (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Mark MacMahon collaborates with scholars based in United Kingdom, United States and Ireland. Mark MacMahon's co-authors include Rodney Bluestone, J.M. Dawson, Ralph H. Stern, Neil Hounslow, Robert Abel, Stephen C. Olson, Bingbing Yang, Lindsey Cass, Jonathan A. Tobert and Alan Bye and has published in prestigious journals such as Gut, Journal of Thrombosis and Haemostasis and Journal of Hypertension.

In The Last Decade

Mark MacMahon

16 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark MacMahon United Kingdom	11	156	96	66	54	50	16	402
Won Ki Min South Korea	12	193 1.2×	47 0.5×	75 1.1×	38 0.7×	46 0.9×	37	521
David Saltissi Australia	13	191 1.2×	96 1.0×	42 0.6×	54 1.0×	26 0.5×	30	587
J N Mount United Kingdom	10	122 0.8×	51 0.5×	114 1.7×	26 0.5×	36 0.7×	14	501
Rosa Maria Marfisi Italy	14	150 1.0×	158 1.6×	76 1.2×	66 1.2×	55 1.1×	20	831
Margus Annuk Sweden	8	112 0.7×	230 2.4×	60 0.9×	83 1.5×	42 0.8×	13	691
Vincenzo Di Garbo Italy	13	137 0.9×	114 1.2×	94 1.4×	102 1.9×	57 1.1×	26	384
Torbjörn Linde Sweden	11	106 0.7×	121 1.3×	46 0.7×	90 1.7×	45 0.9×	24	629
G Perani Italy	12	177 1.1×	182 1.9×	113 1.7×	26 0.5×	75 1.5×	34	738
Davinder Sidhu Canada	8	99 0.6×	51 0.5×	95 1.4×	39 0.7×	60 1.2×	13	510
S. Madsen Denmark	11	288 1.8×	64 0.7×	93 1.4×	124 2.3×	42 0.8×	47	648

Countries citing papers authored by Mark MacMahon

Since Specialization

Citations

This map shows the geographic impact of Mark MacMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark MacMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark MacMahon more than expected).

Fields of papers citing papers by Mark MacMahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark MacMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark MacMahon. The network helps show where Mark MacMahon may publish in the future.

Co-authorship network of co-authors of Mark MacMahon

This figure shows the co-authorship network connecting the top 25 collaborators of Mark MacMahon. A scholar is included among the top collaborators of Mark MacMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark MacMahon. Mark MacMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Reynolds, Thomas C., et al.. (2005). Safety, pharmacokinetics, and immunogenicity of single‐dose rFXIII administration to healthy volunteers. Journal of Thrombosis and Haemostasis. 3(5). 922–928. 32 indexed citations

Cass, Lindsey, Kulasiri A. Gunawardena, Mark MacMahon, & Alan Bye. (2000). Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Respiratory Medicine. 94(2). 166–173. 33 indexed citations

Canal, M., Mark MacMahon, J.T.C. Kwan, & C. Dubruc. (2000). Amisulpride: kinetics in patients with renal failure. European Neuropsychopharmacology. 10. 330–330. 7 indexed citations

Stern, Ralph H., Bingbing Yang, Neil Hounslow, et al.. (2000). Pharmacodynamics and Pharmacokinetic‐Pharmacodynamic Relationships of Atorvastatin, an HMG‐CoA Reductase Inhibitor. The Journal of Clinical Pharmacology. 40(6). 616–623. 64 indexed citations

MacMahon, Mark, et al.. (2000). A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).. PubMed. 10(4). 195–203. 72 indexed citations

MacMahon, Mark. (1999). TREATMENT GUIDELINES FOR HYPERCHOLESTEROLAEMIA: TIME TO CONSIDER SOLUBLE FIBRE. International Journal of Clinical Practice. 53(5). 369–372. 2 indexed citations

Ambrosioni, Ettore, Michel E. Safar, Jean-Paul Degaute, et al.. (1998). Low-dose antihypertensive therapy with 1.5 mg sustained- release indapamide. Journal of Hypertension. 16(11). 1677–1684. 52 indexed citations

MacMahon, Mark & J E Carless. (1998). Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study. Journal of Cardiovascular Risk. 5(3). 167–172. 13 indexed citations

Naoumova, Rossitza P., et al.. (1998). The effect of cholesterol reduction with fluvastatin on aortic compliance, coronary calcification and carotid intimal-medial thickness: a pilot study. Journal of Cardiovascular Risk. 5(1). 1–10. 25 indexed citations

10.

Asmar, Roland, et al.. (1996). [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].. PubMed. 89 Spec No 4. 27–38. 5 indexed citations

11.

MacMahon, Mark, Desmond O’Neill, & Rose Anne Kenny. (1996). Syncope: driving advice is frequently overlooked. Postgraduate Medical Journal. 72(851). 561–563. 16 indexed citations

12.

MacMahon, Mark, J. Lawson, Desmond O’Neill, & Rose Anne Kenny. (1995). Syncope and Driving. Age and Ageing. 24(suppl 1). P12–P12. 2 indexed citations

13.

Kehely, Anne, Mark MacMahon, Mahmoud Barbir, et al.. (1995). Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia. QJM. 88(6). 421–7. 15 indexed citations

14.

MacMahon, Mark, et al.. (1995). Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40???5967), a novel calcium antagonist. Journal of Hypertension. 13(12). 1842???1846–1842???1846. 16 indexed citations

15.

Kehely, Anne, Mark MacMahon, Richard Wray, et al.. (1993). Bezafibrate and Simvastatin: An Effective and Safe Combination to Treat Mixed Hyperlipidaemia. Clinical Science. 85(s29). 20P–20P. 1 indexed citations

16.

Bluestone, Rodney, Mark MacMahon, & J.M. Dawson. (1969). Systemic sclerosis and small bowel involvement.. Gut. 10(3). 185–193. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact